The Supreme Court Friday closed the case seeking action against US-based pharma major Johnson and Johnson for implanting faulty hip implants into patients here, saying that steps have been taken by the Centre to provide compensation upto Rs 1.22 crore to them.
The Supreme Court Friday closed the case seeking action against US-based pharma major Johnson and Johnson for implanting faulty hip implants into patients here, saying that steps have been taken by the Centre to provide compensation upto Rs 1.22 crore to them.
A bench comprising Chief Justice Ranjan Gogoi and Justice S K Kaul considered the response filed by the Union Health Ministry which said that a compensation scheme has been formulated by it to ensure proper compensation to the victims of faulty hip implants.
Disposing of the PIL filed by one Arun Goenka, the top court asked the Centre to widely publicise its compensation scheme to ensure that all the victims of such implants seek help for their grievances.
Earlier, the Centre had informed the apex court that the report of its panel on alleged "faulty" hip implants, made by the pharma major was ready and would be filed within a week.
The PIL had alleged that "faulty" and "deadly" hip implants have been fitted into the bodies of 4,525 Indian patients who had undergone the replacement surgeries since 2005.
Earlier, the Supreme Court has asked the Centre to make publica report of an expert committee that apparently held US-based firm Johnson & Johnson accountable for supplying of over 15,000 defective hip implants in India as well as made it financially liable.
The direction by the apex court came on a public interest litigation that highlighted the Centre's decision of February 2017 to form a panel under Dr Arun Agarwal, an ENT professor at Maulana Azad Medical College, Delhi, to look into the allegations of faulty implants sold by the pharma giant and fix responsibility.
Petitioner Arun Goenka said his mother died of complications after receiving a hip implant, made by DePuy, a subsidiary of J&J, in 2009. Senior advocate Salman Khurshid, who represented Goenka, said the Food and Drug Administration, Mumbai, had lodged a criminal complaint against J&J and DePuy in 2011. But no action was taken, he said.
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
 "Supreme Court closes case against Johnson and Johnson for faulty hip implants")
){kind=small}
){kind=small}
){kind=small}
){kind=small}
)
){kind=small}
){kind=small}
)
)
)
)
)
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}